Thromb Haemost 1972; 28(01): 054-064
DOI: 10.1055/s-0038-1649041
Original Article
Schattauer GmbH

Protein Synthesis by Human Blood Platelets after Accumulation of Leucine and Arginine

D.J Boullin
*   British Industrial Biological research Association, Woodmansterne Road, carshalton, Surrey, England
,
M Votavova
**   Institute of Pharmacology, Academy of sciences, Prague, Czechoslovakia
,
A.R Green
1   Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, Washington, D. C. 20032
› Author Affiliations
Further Information

Publication History

Publication Date:
29 June 2018 (online)

Summary

Human blood platelets resuspended in calcium-free Krebs solution accumulated radioactive L-leucine and L-arginine. The tissue/medium concentration ratio (Ci/Co) was greater than 10:1 when Co was 10–7 M or lower. Accumulation was inhibited by incubation at 4° C, the presence of metabolic inhibitors or platelet soniñcation at the beginning of the experiment. It is considered that these compounds are accumulated by energy-dependent processes against a concentration gradient.

In the presence of 19 other amino acids accumulation of leucine or arginine was greatly reduced. Under these conditions some incorporation of radioactivity into proteins occurred. However, incorporation was small. Both compounds were incorporated similarly despite the fact that arginine is metabolized to ornithine, whilst leucine has no detectable metabolites. This fact is discussed in relation to the possible physiological significance of platelet protein synthesis.

 
  • References

  • 1 Booyse F, and Rafelson M. E. 1968; Studies on human platelet. I Synthesis of platelet protein in a cell free system. Biochimica et Biophysica Acta 116: 689.
  • 2 Booyse F, and Rafelson M. E. 1967; In vitro incorporation of amino acids into the contractile protein of human blood platelets. Nature 215: 283.
  • 3 Boullin D. J, and O’Brien R. A. 1971; Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down’s Syndrome. Journal of Physiology 212: 287.
  • 4 Boullin D. J, and O’Brien R. A. 1969; The accumulation of guanethadine by human blood platelets. British Journal of Pharmacology 35: 90.
  • 5 Cooper I. A, and Firkin B. G. 1970; Amino acid transport into human platelets and subsequent incorporation into protein. Thrombosis et Diathesis Haemorrhagica 23: 140.
  • 6 Costa E, Spano P. G, Gropetti A, Algeri S, and Neff N. H. 1969; Simultaneous determination of tryptophan, tyrosine, catecholamine and serotonin specific activity in rat brain. Atti Della Accademici Medica Lombarda 23: 1.
  • 7 Lamb A. J, Clark-Walker G. D, and Linnane A. W. 1968; The biogenesis of mitochrondria. 4. The differentiation of mitochondrial and cytoplasmic protein synthesising systems in vitro by antibiotics. Biochimica et Biophysica Acta 161: 415.
  • 8 Marcus A. J, and Zucker M. B. 1965. The Physiology of Blood Platelets; Recent Biochemical, Morphologic and Clinical Research. Grune; New York:
  • 9 Michal F, and Firkin B. G. 1969; Physiological and pharmacological aspects of the platelet. Annual Review of Pharmacology 9: 95.
  • 10 Neame K. D. 1968; A comparison of the transport systems for amino acids in brain, intestine, kidney and tumor. Progress in Brain Research 29: 185.
  • 11 Warshaw A. L, Lasker L, and Shulman N.R. 1967; Protein synthesis by human platelets. Journal of Biological Chemistry 242: 2094.
  • 12 Zieve P. D, and Solomon H. M. 1968; Uptake of amino acids by the human platelet. American Journal of Physiology 214: 58.